Posted Feb. 7, 2012 at 6:19 a.m.

Premium Lock Startup Chimerix reports positive test news for transplant drug

Published: 2012-02-07 06:19:23
Updated: 2012-02-07 06:19:23

Print this blog post
Chimerix Chimerix

The company is studying the compound for the prevention of cytomegalovirus diseases, or CMV, in patients who have had stem cell transplants....

Read More
Read More

Copyright 2014 MedCity. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll